Combination of lutetium-177 labelled anti-L1CAM antibody chCE7 with the clinically relevant protein kinase inhibitor MK1775: a novel combination against human ovarian carcinoma

Choose the citation style.
Lindenblatt, D., Terraneo, N., Pellegrini, G., Cohrs, S., Spycher, P. R., Vukovic, D., … Grünberg, J. (2018). Combination of lutetium-177 labelled anti-L1CAM antibody chCE7 with the clinically relevant protein kinase inhibitor MK1775: a novel combination against human ovarian carcinoma. BMC Cancer, 18, 922 (14 pp.). https://doi.org/10.1186/s12885-018-4836-1